Apigenin protects against bleomycin‑induced lung fibrosis in rats

Experimental and Therapeutic Medicine

Volumn 11, Issue 1, 2016, Pages 230-234

  Chen, Ling ^a   Zhao, Wei ^b  

^a China Pingmei Shenma Group   (China)

^b THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

Apigenin; Bleomycin; Lung fibrosis; Transforming growth factor ; Tumor necrosis factor

Indexed keywords

APIGENIN; BLEOMYCIN; HYDROXYPROLINE; MYELOPEROXIDASE; SUPEROXIDE DISMUTASE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; BIOCHEMICAL ANALYSIS; BLEOMYCIN-INDUCED PULMONARY FIBROSIS; BODY WEIGHT; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; EXPERIMENTAL DESIGN; HISTOLOGY; LUNG INFLATION; LUNG INJURY; MALE; NONHUMAN; PROTEIN DEPLETION; RAT;

EID: 84949452261     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2015.2885     Document Type: Article

References (33)

1. Gross TJ and Hunninghake GW: Idiopathic pulmonary fibrosis. N Engl J Med 345: 517-525, 2001.
2. Dempsey OJ and Miller D: Idiopathic pulmonary fibrosis. BMJ 347: f6579, 2013.
3. Mahendran S and Sethi T: Treatments in idiopathic pulmonary fibrosis: Time for a more targeted approach? QJM 105: 929-934, 2012.
4. Villar A, Gasco MA and Alcaraz MJ: Anti-inflammatory and anti-ulcer properties of hypolaetin-8-glucoside, a novel plant flavonoid. J Pharm Pharmacol 36: 820-823, 1984.
5. Gerdin B and Svensjö E: Inhibitory effect of the flavonoid O-(beta-hydroxyethyl)-rutoside on increased microvascular permeability induced by various agents in rat skin. Int J Microcirc Clin Exp 2: 39-46, 1983.
6. Agarwal OP: The anti-inflammatory action of nepitrin, a flavonoid. Agents Actions 12: 298-302, 1982.
7. Clere N, Faure S, Martinez MC and Andriantsitohaina R: Anticancer properties of flavonoids: Roles in various stages of carcinogenesis. Cardiovasc Hematol Agents Med Chem 9: 62-77, 2011.
8. Czyz J, Madeja Z, Irmer U, Korohoda W and Hülser DF: Flavonoid apigenin inhibits motility and invasiveness of carcinoma cells in vitro. Int J Cancer 114: 12-18, 2005.
9. Shukla S and Gupta S: Apigenin-induced cell cycle arrest is mediated by modulation of MAPK, PI3K-Akt and loss of cyclin D1 associated retinoblastoma dephosphorylation in human prostate cancer cells. Cell Cycle 6: 1102-1114, 2007.
10. Nicholas C, Batra S, Vargo MA, Voss OH, Gavrilin MA, Wewers MD, Guttridge DC, Grotewold E and Doseff AI: Apigenin blocks lipopolysaccharide-induced lethality in vivo and proinflammatory cytokines expression by inactivating NF-kappaB through the suppression of p65 phosphorylation. J Immunol 179: 7121-7127, 2007.
11. Duarte S, Arango D, Parihar A, Hamel P, Yasmeen R and Doseff AI: Apigenin protects endothelial cells from lipopolysaccharide (LPS)-induced inflammation by decreasing caspase-3 activation and modulating mitochondrial function. Int J Mol Sci 14: 17664-17679, 2013.
12. Zhang X, Wang G, Gurley EC and Zhou H: Flavonoid apigenin inhibits lipopolysaccharide-induced inflammatory response through multiple mechanisms in macrophages. PloS One 9: e107072, 2014.
13. Liao Y, Shen W, Kong G, Lv H, Tao W and Bo P: Apigenin induces the apoptosis and regulates MAPK signaling pathways in mouse macrophage ANA-1 cells. PloS One 9: e92007, 2014.
14. Kowalski J, Samojedny A, Paul M, Pietsz G and Wilczok T: Effect of apigenin, kaempferol and resveratrol on the expression of interleukin-1beta and tumor necrosis factor-alpha genes in J774.2 macrophages. Pharmacol Rep 57: 390-394, 2005.
15. Wang J, Liao Y, Fan J, Ye T, Sun X and Dong S: Apigenin inhibits the expression of IL-6, IL-8 and ICAM-1 in DEHP-stimulated human umbilical vein endothelial cells and in vivo. Inflammation 35: 1466-1476, 2012.
16. Lampronti I, Borgatti M, Vertuani S, Manfredini S and Gambari R: Modulation of the expression of the proinflammatory IL-8 gene in cystic fibrosis cells by extracts deriving from olive mill waste water. Evid Based Complement Alternat Med 2013: 960603, 2013.
17. Huang CS, Lii CK, Lin AH, Yeh YW, Yao HT, Li CC, Wang TS and Chen HW: Protection by chrysin, apigenin and luteolin against oxidative stress is mediated by the Nrf2-dependent up-regulation of heme oxygenase 1 and glutamate cysteine ligase in rat primary hepatocytes. Arch Toxicol 87: 167-178, 2013.
18. Han JY, Ahn SY, Kim CS, Yoo SK, Kim SK, Kim HC, Hong JT and Oh KW: Protection of apigenin against kainate-induced excitotoxicity by anti-oxidative effects. Biol Pharm Bull 35: 1440-1446, 2012.
19. Jin BH, Qian LB, Chen S, Li J, Wang HP, Bruce IC, Lin J and Xia Q: Apigenin protects endothelium-dependent relaxation of rat aorta against oxidative stress. Eur J Pharmacol 616: 200-205, 2009.
20. Ricupero DA, Poliks CF, Rishikof DC, Kuang PP and Goldstein RH: Apigenin decreases expression of the myofibroblast phenotype. FEBS Lett 506: 15-21, 2001.
21. Wojcik KA, Skoda M, Koczurkiewicz P, Sanak M, Czyż J and Michalik M: Apigenin inhibits TGF-β1 induced fibroblast-to-myofibroblast transition in human lung fibroblast populations. Pharmacol Rep 65: 164-172, 2013.
22. Tarnell EB, Oliver BL, Johnson GM, Watts FL and Thrall RS: Superoxide anion production by rat neutrophils at various stages of bleomycin-induced lung injury. Lung 170: 41-50, 1992.
23. Oury TD, Thakker K, Menache M, Chang LY, Crapo JD and Day BJ: Attenuation of bleomycin-induced pulmonary fibrosis by a catalytic antioxidant metalloporphyrin. Am J Respir Cell Mol Biol 25: 164-169, 2001.
24. Kinnula VL, Fattman CL, Tan RJ and Oury TD: Oxidative stress in pulmonary fibrosis: A possible role for redox modulatory therapy. Am J Respir Crit Care Med 172: 417-422, 2005.
25. Kuwano K, Nakashima N, Inoshima I, Hagimoto N, Fujita M, Yoshimi M, Maeyama T, Hamada N, Watanabe K and Hara N: Oxidative stress in lung epithelial cells from patients with idiopathic interstitial pneumonias. Eur Respir J 21: 232-240, 2003.
26. Bellocq A, Azoulay E, Marullo S, Flahault A, Fouqueray B, Philippe C, Cadranel J and Baud L: Reactive oxygen and nitrogen intermediates increase transforming growth factor-beta1 release from human epithelial alveolar cells through two different mechanisms. Am J Respir Cell Mol Biol 21: 128-136, 1999.
27. Salvemini D, Riley DP and Cuzzocrea S: SOD mimetics are coming of age. Nat Rev Drug Discov 1: 367-374, 2002.
28. Piguet PF, Ribaux C, Karpuz V, Grau GE and Kapanci Y: Expression and localization of tumor necrosis factor-alpha and its mRNA in idiopathic pulmonary fibrosis. Am J Pathol 143: 651-655, 1993.
29. Yara S, Kawakami K, Kudeken N, Tohyama M, Teruya K, Chinen T, Awaya A and Saito A: FTS reduces bleomycin-induced cytokine and chemokine production and inhibits pulmonary fibrosis in mice. Clin Exp Immunol 124: 77-85, 2001.
30. Bhatia M, Zemans RL and Jeyaseelan S: Role of chemokines in the pathogenesis of acute lung injury. Am J Respir Cell Mol Biol 46: 566-572, 2012.
31. Martin TR and Matute-Bello G: Experimental models and emerging hypotheses for acute lung injury. Crit Care Clin 27: 735-752, 2011.
32. Anscher MS: Targeting the TGF-beta1 pathway to prevent normal tissue injury after cancer therapy. Oncologist 15: 350-359, 2010.
33. Wilson MS, Madala SK, Ramalingam TR, Gochuico BR, Rosas IO, Cheever AW and Wynn TA: Bleomycin and IL-1beta-mediated pulmonary fibrosis is IL-17A dependent. J Exp Med 207: 535-552, 2010.